Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2024

Jun 3, 2024

3091_iss_2024-06-03_3a164e22-767f-485a-8438-1a7b2b886178.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary Shares
Before the transaction
Shares 8,285,258
Voting rights 8,285,258
Transaction
Reason for major shareholding notification Corporate action
Date 31/05/2024
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 8,285,258
Directly held voting rights 8,285,258
Indirectly held voting rights 0
Percentage
Directly held shares 3.85027 %
Directly held voting rights 3.91846 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 3.91846 % 8,285,258
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 3.91846 % 8,285,258
Group
total
holdings
Voting rights
8,285,258
Percentage of voting rights 3.91846
Notes (other relevant informations according to law)
Changes due to: Corporate action, Rights issue
Published
03/06/2024 09:30
Contact
Name
Caroline Murray

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25